ADC

2개 · ADC 890 · Antibody 4097 · CGT 2985 · 다음 갱신 D-6 · 마지막 9월 2일

PopularRecently updatedCuratedMost trialsNeeds refreshORRLatestPhase 3FDA approved2 programs
ADCStandard DatabasestalePfizerPhase 3

Inotuzumab ozogamicin (Inotuzumab ozogamicin)

B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative; Recurrent B Acute Lymphoblastic Leukemia · Precursor Cell Lymphoblastic Leukemia-Ly

#PrecursorCellLymphoblasticLeukem#ADC#Phase3#Popular#antibody-drug-conjugate+5
Trials 53Status Recruiting
ADCLimited DatastaleAmgenPhase 2

Blinatumomab and Inotuzumab Ozogamicin (Blinatumomab and Inotuzumab Ozogamicin)

Acute Lymphoblastic Leukemia; Immunotherapy · Acute Lymphoblastic Leukemia

#AcuteLymphoblasticLeukemia#ADC#Phase2#antibody-drug-conjugate#Immunotherapy+1
Trials 1Status Recruiting